CBR1

protein-coding

carbonyl reductase 1, the group of Short chain dehydrogenase/reductase superfamily

Gene summary

The protein encoded by this gene belongs to the short-chain dehydrogenases/reductases (SDR) family, which function as NADPH-dependent oxidoreductases having wide specificity for carbonyl compounds, such as quinones, prostaglandins, and various xenobiotics. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2013]

Previous symbols:
  • CBR

MANE transcript

NM_001757.4

Inheritance

—

ClinVar variants

U:46B:4

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.83

Max pathogenic AF

—

Genomic locus

chr21:36,069,941-36,073,166

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~3.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CBR1 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 47
not providedTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001757.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
46
clinvar
3
clinvar
49
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00463150
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 19 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001757.4RefSeqNP_001748.13MANE Select
ENST00000290349.11EnsemblENSP00000290349.63MANE Select
NM_001286789.2RefSeqNP_001273718.13Standard
ENST00000399191.3EnsemblENSP00000382143.33Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Folate biosynthesis - Homo sapiens (human)
  • Doxorubicin Pathway (Cardiomyocyte Cell), Pharmacodynamics
  • Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human)
  • Arachidonic acid metabolism - Homo sapiens (human)
  • Doxorubicin Pathway, Pharmacokinetics

Biological Process

  • drug metabolic process
  • cyclooxygenase pathway
  • epithelial cell differentiation
  • vitamin K metabolic process
  • oxidation-reduction process

Molecular Function

  • carbonyl reductase (NADPH) activity
  • oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
  • 15-hydroxyprostaglandin dehydrogenase (NADP+) activity
  • prostaglandin-E2 9-reductase activity

Cellular Component

  • cytosol
  • extracellular exosome
  • extracellular vesicle

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000290349
Coding exons
3
Length
3226
Individuals with no LoFs
125711
Homozygous LoFs
0
Heterozygous LoFs
37
Defined
125748
p
0.000147
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.09061641611.020.000008131788
Missense (PolyPhen)4545.210.99535553
Synonymous-1.538770.61.230.00000394568
Loss of Function0.46078.440.8294.44e-792

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000120.00012rare
Latino/Admixed American0.000120.00012rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.000140.000092rare
European (Non-Finnish)0.000120.00011rare
South Asian0.000530.00052rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione. {ECO:0000269|PubMed:15799708, ECO:0000269|PubMed:17912391, ECO:0000269|PubMed:18449627, ECO:0000269|PubMed:18826943}.;

Recessive Scores

pRec
0.267

Intolerance Scores

LoFtool
0.372
RVIS EVS
-0.03
RVIS percentile EVS
51.66

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.994

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.